The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice
The cationic liposome DOTAP is a well-known transfection reagent. It has been manufactured and approved for clinical use, is readily available, and can be easily used as an adjuvant. These characteristics prompted us to investigate the effectiveness of DOTAP as an adjuvant to induce immune responses...
Saved in:
Published in | Journal of immunotherapy (1997) Vol. 21; no. 3; p. 159 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.1998
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!